SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001213900-21-025888
Filing Date
2021-05-12
Accepted
2021-05-12 21:54:40
Documents
2
Period of Report
2021-05-12

Document Format Files

Seq Description Document Type Size
1 ownership.html 3  
1 ownership.xml 3 3334
2 POWER OF ATTORNEY ea140709ex24_orionbiotech.htm EX-24 12085
  Complete submission text file 0001213900-21-025888.txt   16760
Mailing Address C/O SENSEI BIOTHERAPEUTICS, INC. 1405 RESEARCH DR., STE. 125 ROCKVILLE MD 20850
Business Address
Broder Samuel (Reporting) CIK: 0001340543 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-40410 | Film No.: 21916979

Mailing Address 645 FIFTH AVENUE, 21ST FLOOR NEW YORK NY 10022
Business Address 645 FIFTH AVENUE, 21ST FLOOR NEW YORK NY 10022 212-303-7822
Orion Biotech Opportunities Corp. (Issuer) CIK: 0001847416 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
SIC: 6770 Blank Checks